Lista de obras - Karine Lacombe - Dominio Público Uruguay

A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient.

artículo científico publicado en 2006

Acute hepatic cytolysis in an HIV-infected patient taking atazanavir

artículo científico publicado en 2004

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort

artículo científico publicado en 2016

An improved understanding of severe liver morbidity in HIV-infected individuals

artículo científico publicado en 2016

Campylobacter bacteremia: clinical features and factors associated with fatal outcome.

artículo científico publicado en 2008

Chlamydia trachomatis screening in urine among asymptomatic men attending an STI clinic in Paris: a cross-sectional study

artículo científico publicado en 2019

Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.

artículo científico publicado en 2011

Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients

artículo científico publicado en 2008

Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV.

artículo científico publicado en 2008

Correlates of poor perceived health among individuals living with HIV and HBV chronic infections: a longitudinal assessment

article

Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region

artículo científico publicado en 2014

Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients

artículo científico publicado en 2016

Determinants of adherence to non-occupational post HIV exposure prophylaxis

scientific article published on 01 January 2006

Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients

artículo científico publicado en 2017

Drug-resistant and immune-escape HBV mutants in HIV-infected hosts.

artículo científico publicado en 2010

Effect of tenofovir with and without interferon on hepatitis D virus replication in HIV-hepatitis B virus-hepatitis D virus-infected patients

artículo científico publicado en 2013

Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study

artículo científico publicado en 2016

Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort

artículo científico publicado en 2017

Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results

artículo científico publicado en 2013

Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough

artículo científico publicado en 2004

Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy

artículo científico publicado en 2010

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

article

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

artículo científico publicado en 2018

Failure of HIV-2 viral load assay in a severely immunodeficient patient: clinical and therapeutic management issues

scientific article published on 15 November 2005

Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM

scientific article published on 19 April 2020

HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study

artículo científico publicado en 2017

Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection

artículo científico publicado en 2018

High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients

artículo científico publicado en 2013

Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification

artículo científico publicado en 2015

Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus

artículo científico publicado en 2007

Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial

artículo científico publicado en 2010

Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin

artículo científico publicado en 2009

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study

artículo científico publicado en 2019

Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study

artículo científico publicado en 2016

Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons

scientific article published on 07 October 2020

Influence of liver fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic hepatitis B or C.

artículo científico publicado en 2009

Influence of pravastatin on carotid artery structure and function in dyslipidemic HIV-infected patients receiving antiretroviral therapy

article

Kinetics of hepatitis B core-related antigen and anti-hepatitis B core antibody and their association with serological response in HIV-hepatitis B co-infection

artículo científico publicado en 2020

Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients

artículo científico publicado en 2012

Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)

artículo científico publicado en 2020

Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use.

artículo científico publicado en 2010

Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study

artículo científico publicado en 2017

Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals

artículo científico publicado en 2015

Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate

artículo científico publicado en 2005

Low incidence of precore W28* mutant variants in treated hepatitis B virus and human immunodeficiency virus co-infected patients

artículo científico publicado en 2017

Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire

artículo científico publicado en 2015

Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.

artículo científico publicado en 2006

Metabolic disorders and cardiovascular risk in treatment-naive HIV-infected patients of sub-saharan origin starting antiretrovirals: impact of westernized lifestyle

artículo científico publicado en 2015

Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients

artículo científico publicado en 2017

Non-O:1 and non-O:139 Vibrio cholerae septicemia and pyomyositis in an immunodeficient traveler returning from Tunisia

artículo científico publicado en 2006

Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.

artículo científico publicado en 2009

Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France

article

Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications

artículo científico publicado en 2014

Plasma HIV-RNA is the key determinant of long-term antibody persistence after Yellow fever immunization in a cohort of 364 HIV-infected patients

artículo científico publicado en 2012

Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study

artículo científico publicado en 2015

Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus.

artículo científico publicado en 2013

Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus

artículo científico publicado en 2015

Renal outcomes after up to 8 years of tenofovir exposure in HIV-HBV-coinfected patients

artículo científico publicado en 2016

Response to: 'Does the prevalence of radiographic hand osteoarthritis in patients with HIV-1 infection increase or not?' by Luo et al

artículo científico publicado en 2016

Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients

artículo científico publicado en 2010

Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen

artículo científico publicado en 2005

Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.

artículo científico publicado en 2007

Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage

artículo científico publicado en 2015

Sustained increase of HDL cholesterol over a 72-week period in HIV-infected patients exposed to an antiretroviral regimen including lopinavir/ritonavir

artículo científico publicado en 2008

Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized persons

artículo científico publicado en 2017

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010 ⬇️

artículo científico publicado el 22 de octubre de 2010

The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients

artículo científico publicado en 2017

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients

artículo científico publicado en 2015

Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals

article

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

article

Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study

artículo científico publicado en 2018

Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.

artículo científico publicado en 2014

[HIV infection]

scientific article published on 01 September 2003

Lista de obras de Karine Lacombe

A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient.

Acute hepatic cytolysis in an HIV-infected patient taking atazanavir

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort

An improved understanding of severe liver morbidity in HIV-infected individuals

Campylobacter bacteremia: clinical features and factors associated with fatal outcome.

Chlamydia trachomatis screening in urine among asymptomatic men attending an STI clinic in Paris: a cross-sectional study

Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.

Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients

Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV.

Correlates of poor perceived health among individuals living with HIV and HBV chronic infections: a longitudinal assessment

Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region

Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients

Determinants of adherence to non-occupational post HIV exposure prophylaxis

Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients

Drug-resistant and immune-escape HBV mutants in HIV-infected hosts.

Effect of tenofovir with and without interferon on hepatitis D virus replication in HIV-hepatitis B virus-hepatitis D virus-infected patients

Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study

Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort

Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results

Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough

Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

Failure of HIV-2 viral load assay in a severely immunodeficient patient: clinical and therapeutic management issues

Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM

HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study

Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection

High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients

Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification

Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus

Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial

Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study

Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study

Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons

Influence of liver fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic hepatitis B or C.

Influence of pravastatin on carotid artery structure and function in dyslipidemic HIV-infected patients receiving antiretroviral therapy

Kinetics of hepatitis B core-related antigen and anti-hepatitis B core antibody and their association with serological response in HIV-hepatitis B co-infection

Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients

Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)

Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use.

Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study

Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals

Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate

Low incidence of precore W28* mutant variants in treated hepatitis B virus and human immunodeficiency virus co-infected patients

Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire

Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.

Metabolic disorders and cardiovascular risk in treatment-naive HIV-infected patients of sub-saharan origin starting antiretrovirals: impact of westernized lifestyle

Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients

Non-O:1 and non-O:139 Vibrio cholerae septicemia and pyomyositis in an immunodeficient traveler returning from Tunisia

Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.

Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France

Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications

Plasma HIV-RNA is the key determinant of long-term antibody persistence after Yellow fever immunization in a cohort of 364 HIV-infected patients

Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study

Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus.

Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus

Renal outcomes after up to 8 years of tenofovir exposure in HIV-HBV-coinfected patients

Response to: 'Does the prevalence of radiographic hand osteoarthritis in patients with HIV-1 infection increase or not?' by Luo et al

Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients

Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen

Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.

Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage

Sustained increase of HDL cholesterol over a 72-week period in HIV-infected patients exposed to an antiretroviral regimen including lopinavir/ritonavir

Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized persons

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010 ⬇️

The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients

Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study

Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.

[HIV infection]